La Madeleine, France

Anne-Sophie Debrie

This inventor holds 8 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignees: Institut Pasteur De Lille, National Institute of Health and Medical Research, Other. Active years: 2015-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anne-Sophie Debrie. Retrieved from https://idiyas.com/inventor/anne-sophie-debrie

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 4.3

ph-index = 3

Forward Citations = 13(Granted Patents)


Location History:

  • Lille, FR (2015)
  • La Madeleine, FR (2015 - 2022)

Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Anne-Sophie Debrie of La Madeleine, France

Introduction

Anne-Sophie Debrie is a distinguished inventor based in La Madeleine, France, known for her significant contributions to the field of biomedical research. With a portfolio of 8 patents, her innovative work primarily focuses on developing effective solutions against various bacterial strains.

Latest Patents

One of her latest innovations involves the development of strains expressing serotype 3 fimbriae. Specifically, she has created a Fim3-producing BPZE1 derivative that boasts stable fim3 expression, which offers enhanced protection in mice against clinical isolates that only produce Fim3. Importantly, the fim3 expression in BPZE1f3 has been shown not to compromise protective efficacy against Fim2+ strains or strains that do not produce either Fim2 or Fim3. This advancement highlights her dedication to improving protective measures against bacterial infections.

Career Highlights

Throughout her career, Anne-Sophie Debrie has worked with reputable organizations, including the Institut Pasteur de Lille. Her research and inventions have played a critical role in advancing medical science, particularly in understanding and targeting bacterial pathogens.

Collaborations

Anne-Sophie has collaborated with prominent figures in her field, including Camille Locht and Dominique Raze. These partnerships have facilitated groundbreaking research and innovations, contributing to her impressive body of work.

Conclusion

With her expertise and innovative spirit, Anne-Sophie Debrie continues to be a pivotal figure in biomedical research. Her latest patents signify her commitment to combating bacterial infections and enhancing public health through scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…